Endostatin phenylalanines 31 and 34 define a receptor binding site

Genes to Cells

Volumn 10, Issue 9, 2005, Pages 929-939

  Stahl, Sonja ^a   Gaetzner, Sabine ^a   Mueller, Thomas D ^a   Felbor, Ute ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ENDOSTATIN; HEPARIN; HEPARIN BINDING PROTEIN; HYBRID PROTEIN; LAMININ; PHENYLALANINE; COLLAGEN TYPE 18;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BLINDNESS; CHROMATOGRAPHY; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYDROPHOBICITY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; WESTERN BLOTTING; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SPECIES DIFFERENCE;

MURINAE;

ALKALINE PHOSPHATASE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; COLLAGEN TYPE XVIII; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOSTATINS; HEPARIN; HUMANS; LAMININ; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHENYLALANINE; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY;

EID: 24344438588     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2005.00890.x     Document Type: Article

References (45)

1. Ackley, B.D., Crew, J.R., Elamaa, H., Pihlajaniemi, T., Kuo, C.J. & Kramer, J.M. (2001) The NC1/endostatin domain of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance. J. Cell Biol. 152, 1219-1232.
2. Antonarakis, S.E., Reymond, A., Menzel, O., et al. (2005) A response to Suzuki et al. 'How pathogenic is the p.D104N/endostatin polymorphic allele of COL18A1 in Knobloch syndrome?'. Hum. Mutat. 25, 316.
3. Clamp, M., Cuff, J., Searle, S.M. & Barton, G.J. (2004) The Jalview Java alignment editor. Bioinformatics 20, 426-427.
4. Czeizel, A.E., Goblyos, P., Kustos, G., Mester, E. & Paraicz, E. (1992) The second report of Knobloch syndrome. Am. J. Med. Genet. 42, 777-779.
5. Ding, Y.H., Javaherian, K., Lo, K.M., et al. (1998) Zinc-dependent dimers observed in crystals of human endostatin. Proc. Natl. Acad. Sci. USA 95, 10443-10448.
6. Felbor, U., Dreier, L., Bryant, R.A., Ploegh, H.L., Olsen, B.R. & Mothes, W. (2000) Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 19, 1187-1194.
7. Flanagan, J.G. & Cheng, H.J. (2000) Alkaline phosphatase fusion proteins for molecular characterization and cloning of receptors and their ligands. Methods Enzymol. 327, 198-210.
8. Flanagan, J.G., Cheng, H.J., Feldheim, D.A., Hattori, M., Lu, Q. & Vanderhaeghen, P. (2000) Alkaline phosphatase fusions of ligands or receptors as in situ probes for staining of cells, tissues, and embryos. Methods Enzymol. 327, 19-35.
9. Fukai, N., Eklund, L., Marneros, A.G., et al. (2002) Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21, 1535-1544.
10. Gaetzner, S., Deckers, M.M.L., Stahl, S., Löwik, C., Olsen, B.R. & Felbor, U. (2005) Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants. Matrix Biol. 23, 557-561.
11. Gitay-Goren, H., Soker, S., Vlodavsky, I. & Neufeld, G. (1992) The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267, 6093-6098.
12. Hohenester, E., Sasaki, T., Olsen, B.R. & Timpl, R. (1998) Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution. EMBO J. 17, 1656-1664.
13. Hohenester, E., Sasaki, T., Mann, K. & Timpl, R. (2000) Variable zinc coordination in endostatin. J. Mol. Biol. 297, 1-6.
14. Iughetti, P., Suzuki, O., Godoi, P.H., et al. (2001) A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Cancer Res. 61, 7375-7378.
15. Javaherian, K., Park, S.Y., Pickl, W.F., et al. (2002) Laminin modulates morphogenic properties of the collagen XVIII endostatin domain. J. Biol. Chem. 277, 45211-45218.
16. Karumanchi, S.A., Jha, V., Ramchandran, R., et al. (2001) Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell 7, 811-822.
17. Kliemann, S.E., Waetge, R.T., Suzuki, O.T., Passos-Bueno, M.R. & Rosemberg, S. (2003) Evidence of neuronal migration disorders in Knobloch syndrome: clinical and molecular analysis of two novel families. Am. J. Med. Genet. 119A, 15-19.
18. Knobloch, W. & Layer, J. (1971) Retinal detachment and encephalocele. J. Pediatric Ophthalmol. 8, 181-184.
19. Li, H.C., Cai, Q.Y., Shinohara, E.T., et al. (2005) Endostatin polymorphism 4349G/A (D104N) is not associated with aggressiveness of disease in prostate cancer. Dis. Markers 21, 37-41.
20. Macpherson, G.R., Singh, A.S., Bennett, C.L., et al. (2004) Genotyping and functional analysis of the D104N variant of human endostatin. Cancer Biol. Ther. 3, 1298-1303.
21. Marneros, A.G. & Olsen, B.R. (2003) Age-dependent iris abnormalities in collagen XVIII/endostatin deficient mice with similarities to human pigment dispersion syndrome. Invest. Ophthalmol. Vis. Sci. 44, 2367-2372.
22. Marneros, A.G., Keene, D.R., Hansen, U., et al. (2004) Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J. 23, 89-99.
23. Menzel, O., Bekkeheien, R.C., Reymond, A., et al. (2004) Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin. Hum. Mutat. 23, 77-84.
24. Oh, S.P., Kamagata, Y., Muragaki, Y., Timmons, S., Ooshima, A. & Olsen, B.R. (1994a) Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc. Natl. Acad. Sci. USA 91, 4229-4233.
25. Oh, S.P., Warman, M.L., Seldin, M.F., et al. (1994b) Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1 (XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 19, 494-499.
26. Olsson, A.K., Johansson, I., Akerud, H., et al. (2004) The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization. Cancer Res. 64, 9012-9017.
27. O'Reilly, M.S., Boehm, T., Shing, Y., et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
28. Passos-Bueno, M.R., Marie, S.K., Monteiro, M., et al. (1994) Knobloch syndrome in a large Brazilian consanguineous family: confirmation of autosomal recessive inheritance. Am. J. Med. Genet. 52, 170-173.
29. Rehn, M. & Pihlajaniemi, T. (1994) Alpha 1 (XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc. Natl. Acad. Sci. USA 91, 4234-4238.
30. Rehn, M., Veikkola, T., Kukk-Valdre, E., et al. (2001) Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA 98, 1024-1029.
31. Rychkova, N., Stahl, S., Gaetzner, S. & Felbor, U. (2005) Non-heparan sulfate-binding interactions of endostatin/collagen XVIII in murine development. Dev. Dyn. 232, 399-407.
32. Sasaki, T., Fukai, N., Mann, K.G., Göhring, W., Olsen, B.R. & Timpl, R. (1998) Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17, 4249-4256.
33. Sasaki, T., Larsson, H., Kreuger, J., et al. (1999) Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 18, 6240-6248.
34. Sasaki, T., Larsson, H., Tisi, D., Claesson-Welsh, L., Hohenester, E. & Timpl, R. (2000) Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J. Mol. Biol. 301, 1179-1190.
35. Seaver, L.H., Joffe, L., Spark, R.P., Smith, B.L. & Hoyme, H.E. (1993) Congenital scalp defects and vitreoretinal degeneration: redefining the Knobloch syndrome. Am. J. Med. Genet. 46, 203-208.
36. Sertié, A.L., Sossi, V., Camargo, A.A., Zatz, M., Brahe, C. & Passos-Bueno, M.R. (2000) Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum. Mol. Genet. 9, 2051-2058.
37. Sniderman, L.C., Koenekoop, R.K., O'Gorman, A.M., et al. (2000) Knobloch syndrome involving midline scalp defect of the frontal region. Am. J. Med. Genet. 90, 146-149.
38. Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M. & Kalluri, R. (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc. Natl. Acad. Sci. USA 100, 4766-4771.
39. Suzuki, O.T., Sertié, A.L., Der Kaloustian, V.M., et al. (2002) Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am. J. Hum. Genet. 71, 1320-1329.
40. Suzuki, O.T., Bagatini, K., Sertié, A.L. & Passos-Bueno, M. (2005) How pathogenic is the p.D104N/endostatin polymorphic allele of COL18A1 in Knobloch syndrome? Hum. Mutat. 25, 314-315.
41. Utriainen, A., Sormunen, R., Kettunen, M., et al. (2004) Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum. Mol. Genet. 13, 2089-2099.
42. Wickström, S.A., Alitalo, K. & Keski-Oja, J. (2003) Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J. Biol. Chem. 278, 37895-37901.
43. Wickström, S.A., Alitalo, K. & Keski-Oja, J. (2004) An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells. J. Biol. Chem. 279, 20178-20185.
44. Wilson, C., Aftimos, S., Pereira, A. & McKay, R. (1998) Report of two sibs with Knobloch syndrome (encephalocoele and viteroretinal degeneration) and other anomalies. Am. J. Med. Genet. 78, 286-290.
45. Ylikärppä, R., Eklund, L., Sormunen, R., et al. (2003) Lack of type XVIII collagen results in anterior ocular defects. FASEB J. 17, 2257-2259.